Clin2
NCT07704255Possibly a fitRecruiting

Fecal transplant for stubborn H. pylori infection

Helicobacter Pylori Infection

Part of Digestive system, Infections clinical trials.

This study tries a fecal microbiota transplant (placing healthy donor stool into your gut) to get rid of stubborn H. pylori infection that hasn't been cured by standard treatments. It's for people who have failed several rounds of therapy and have a stomach condition that makes eradication important.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
10 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 70 years old.
  • Standard H. pylori treatments have failed you at least 4 times.
  • You have a stomach condition such as early stomach cancer, an ulcer, a type of lymphoma called MALT, or atrophic gastritis.
  • You haven't taken antibiotics or bismuth in the last 4 weeks, or acid-reducing medicines like omeprazole in the last 2 weeks.
  • You are not pregnant or breastfeeding.
  • You have no other serious diseases or problems that would make the study unsafe for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05329636Recruiting· Phase 1/Phase 2
Fecal microbiome transplant after H. pylori antibiotic treatment

This trial tests whether transplanting healthy gut bacteria (from fecal material) can help your recovery and gut health after you take antibiotics to clear H. pylori (a stomach germ). If you qualify, you would start with confirmed H. pylori and then follow the study steps for the transplant.

Tel Aviv
NCT07405697Not yet recruiting· Phase 4
Stool test guided therapy for H. pylori infection

This study tests if analyzing a stool sample can help choose the right antibiotics to clear a stubborn H. pylori infection that hasn't been cured before. It aims to improve treatment success with fewer side effects.

Shanghai, Shanghai Municipality
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT05121025Recruiting
Study of stomach bacteria and gut microbes in Helicobacter infection

This study looks at how stomach bacteria (Helicobacter pylori) interact with the normal microbes in your gut. You may be asked to provide tissue, stool, and blood samples to help researchers understand infection and the body’s response.

Freiburg im Breisgau, Baden-Wurttemberg
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.